By Sindhu Sundar ( September 18, 2015, 11:23 PM EDT) -- A Missouri woman who accused GlaxoSmithKline LLC of concealing dangerous side effects of its diabetes drug Avandia told the Third Circuit on Friday to revive a proposed class action, arguing that she had sufficiently alleged that the drug failed to live up to its advertised value. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.